TandemAI and Perpetual Medicines Announce Strategic Merger
Combined Firm, Known as TandemAI, Will Build on Synergies of Advanced Artificial Intelligence and Computational Platforms for Small Molecule and Peptide-Based Therapeutics TandemAI, a company transforming drug discovery with state-of-the-art AI and physics-based technologies integrated with full wet lab capabilities, and Perpetual Medicines, which is advancing a computational design-synthesis platform for peptide drug discovery today…
